UK to invest in research on evolving global health threats

  30 September 2019

The UK’s chief medical officer Professor Dame Sally Davies has announced funding for projects to help combat antimicrobial resistance (AMR) and achieve global universal health coverage.

The funding includes: £6.2 million to strengthen existing surveillance systems tracking AMR trends across Africa and Asia; and £12 million to improve collaborations on health systems research between low- and middle-income countries and the UK.

Further reading: PharmaTimes
Author(s): Selina McKee
Effective Surveillance   Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!